Tritrpticin

General Information


DCTPep ID  DCTPep00975

Peptide Name   Tritrpticin

Sequence  VRRFPWWWPFLRR

Sequence Length  13

UniProt ID  Not available

PubChem CID  16134657 

Origin  porcine cathelicidin peptide

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
MDA-MB-361 Breast adenocarcinoma IC50=142 µg/ml MTT assay Not available 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia IC50=18.3 µM MTT assay 24h 1
A549 Lung adenocarcinoma IC50>200 µg/ml MTT assay Not available 1

Hemolytic Activity  RBC: IC50 ≥ 65 µM

Normal (non-cancerous) Cytotoxicity  PBMC: IC50=40.6 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00975

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C96H132N28O14

Absent amino acids  ACDEGHIKMNQSTY

Theoretical pI  12.48

Acidic residues  0

Basic residues  4

Polar residues  0

Molecular weight (Average)  1902.28

Molecular weight (Monoisotopic)  1901.05

Common amino acids  R

Net charge  4

Instability index (II)  139.58

Aliphatic index  52.31

Grand average of hydropathicity (GRAVY)  -0.792

Half Life 
  100 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 16500
  Abs 0.1% (=1 g/l) 8.674

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32126228

Title  Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin

Doi 10.1016/j.bbamem.2020.183228

Year  2020

Literature 2

Pubmed ID 18815734

Title  Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity

Doi 10.1007/s10529-008-9848-5

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.